Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
CLSA noted that when the RBI gave a one-year extension to the MD of RBL Bank, and later appointed a PSU banker, the stock ...
5don MSN
An analyst from StoxBox said that Yes Bank struggles to hold key support levels and lacks clear directional momentum. The RSI ...
JPMorgan analyst Ryan Brinkman lowered the firm’s price target on Tesla (TSLA) to $120 from $135 and keeps an Underweight rating on the shares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback